Bora Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Taiwan · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
6f No. 2 Aly. 36 Ln. 26 Ruiguang Neihu D...Phone Number
+886 227901555Website
www.boracdmo.comRevenue
$65 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Bora Pharmaceuticals
Bora Pharmaceuticals is a pharmaceutical manufacturing and CDMO company that supports biotech and healthcare organizations with drug development, production, and packaging services. They specialize in scalable manufacturing solutions across multiple dosage forms, helping partners streamline operations, maintain quality standards, and accelerate product delivery through integrated pharmaceutical capabilities.Explore more
Bora Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bora Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Bora Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Bora Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Bora Pharmaceuticals
Website visits: Recent activity has been detected on your website
Click to see if Bora Pharmaceuticals had a recent Job posting/layoffs
Bora Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Bora Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Bora Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Bora Pharmaceuticals has new funding data
Recommended Actions
Find VP level buyers at Bora Pharmaceuticals
Find 3 more new buyers
Company Profile Activity
Activity Insights
Bora Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bora Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bora Pharmaceuticals.
Bora Pharmaceuticals Tech Stack
A closer look at the technologies used by Bora Pharmaceuticals
See more technologies
Most Recent Scoops
Earnings
Bora Pharmaceuticals has reported quarterly revenue for its CDMO business of TWD 2.116 billion for Q2 2026, reflecting a 40% increase quarter-over-quarter, driven by record highs in demand and RFPs, with the Maryland injectable facility returning to a full quarter of operations.
Earnings, Finance
Earnings
Bora Pharmaceuticals has reported revenues of TWD 5.8 billion for Q2 2026, reflecting a 21% increase year-over-year from TWD 4.8 billion, with gross profits increasing 20% to TWD 2.4 billion, net income before tax rising 46% to TWD 813 million, and net income from continued operations increasing from TWD 448 million to TWD 600 million.
Earnings, Finance
Earnings
Bora Pharmaceuticals has reported 58% quarter-over-quarter growth in its rare disease specialty pharma franchise (vigabatrin franchise) for Q2 2026, with the company on track to achieve over 50% formulary coverage through expanded regional plans and strong physician adoption, supported by renegotiated supply chain partner terms to increase gross margins.
Earnings, Business Development, Pharmaceuticals, Finance
Earnings
Bora Pharmaceuticals has intensified marketing efforts to capitalize on US CDMO onshoring tailwinds, achieving 400 marketing qualified leads in H1 2026, matching its full-year 2025 total, with inbound and Bora-branded searches surging approximately 3x above expectations.
Digital Marketing, Marketing Campaign, Lead Generation
Earnings
Earnings, Pharmaceuticals, Finance
Bora Pharmaceuticals News & Media
OTC Markets Group Welcomes Bora Pharmaceuticals Co., Ltd. to OTCQX
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Bora Pharmaceuticals Co., Ltd. (TWSE: 6472; OTCQX: BORAY), a premier international contract development and manufacturing organization and specialty pharmaceutical company, has qualified to trade on the OTCQX® Best Market.UPSHER-SMITH LAUNCHES KYMBEE™ (DEFLAZACORT) TABLETS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
Company Reinforces Commitment to Rare Disease Community through its Promise of Support® Program MAPLE GROVE, Minn., Dec. 1, 2025 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of KYMBEE™ (deflazacort) Tablets, indicated for the treatment of...UPSHER-SMITH STRENGTHENS CONNECTIONS WITH THE EPILEPSY COMMUNITY THROUGH AWARENESS, EDUCATION, AND SUPPORT
From Epilepsy Awareness Day at Disneyland to the American Epilepsy Society Annual Meeting, the company continues its mission to improve understanding and care for people living with epilepsy and infantile spasms. MAPLE GROVE, Minn., Nov. 26, 2025 /PRNewswire/ -- Upsher-Smith Laboratories,...Bora Pharmaceuticals acquires Emergent Biosolutions Maryland facility
Approximately 350 employees will transfer to the Taiwan-based drug manufacturer as it looks to expands its North American presence.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bora Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Bora Pharmaceuticals is a pharmaceutical manufacturing and CDMO company that supports biotech and healthcare organizations with drug development, production, and packaging services. They specialize in scalable manufacturing solutions across multiple dosage forms, helping partners streamline operations, maintain quality standards, and accelerate pro... Read More
